The trial data demonstrated a clear clinical benefit in delaying disease progression in eligible patients, offering an additional therapeutic approach in this setting." Novartis unveiled initial data from the PSMAfore study in October 2023
Typically, patients are started on a lower dosage, and as your doctor receives feedback on your progress they may increase your dosage
Philippe K, Teo S, Perrotta C, McAuliffe FM, Phillips CM
Similarly, anyone with acute kidney injury or ongoing dehydration should delay GLP-1 treatment until their kidneys stabilize and fluid balance improves
L-Glutathion (kurz auch nur Glutathion genannt) ist eine natrliche krpereigene Substanz, die in praktisch allen menschlichen Zellen vorkommt
Cagrilintide should be a clear, colorless solution